Screening for chronic Q-fever is only cost-effective for specific groups RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.
Pneumococcal disease in the elderly The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.
Statement on health care spending Down syndrome Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.
Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.
Promising biobased alternatives to controversial polar aprotic solvents There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .
Long-term disruption of day/night rhythms increases risk of breast cancer and leads to gain in bodyweight Long-term disruption of day/night rhythms leads to an increase in breast cancer risk and bodyweight in mice susceptible to breast cancer.
High number of tick bites expected this summer It is expected that over the coming month, around half a million people will be bitten by a tick. Last month, considerably more tick bites have been reported compared to previous years.
Gardner Middlebrook Award 2015 to Dick van Soolingen RIVM congratulates Professor Dick van Soolingen, who was presented the highly coveted Gardner Middlebrook Award.
Annual report RIVM 2014 online In our annual report, we look back at compelling RIVM projects and research in 2014.